Circulating GLP-1 exists only at low picomolar concentrations, is rapidly inactivated by DPP-4 enzymes and is swiftly cleared by the kidneys (Hansen et al., 1999
The best place to inject GLP-1 medications is wherever is easiest and most comfortable for you
For people with type 2 diabetes and early-stage kidney problems, this treatment could offer a better way to protect kidney function and improve overall health
Tirzepatide is an FDA-approved drug with completed Phase 3 obesity trials, while cagrilintide is investigational, with monotherapy data only through Phase 2 and its strongest results coming from the CagriSema combination
The studies by Anholm C, et al
And we deliberately chose exenatide and lixisenatide because they have been used very successfully in the clinic and have a long safety record. Incorporating these GLP-1 therapies into the genome of lettuce also bypasses synthesis challenges faced by oral formulations, such as the need to adjust the stomach acid pH to be less acidic to prevent degradation, he explains